Patent · US Active

Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD)

US10004780B2 · kind B2 · utility

2Cited by

1References

6Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR

Inventors

Thierry Leveillard · Maisons-Alfort, FR
Jose-Alain Sahel · Paris, FR
Therese Cronin · Paris, FR
Leah Byrne · Paris, FR
Ram Fridlich · Paris, FR

Key dates

Filing date	Oct 17, 2013
Grant date	Jun 26, 2018
Priority date	—
Expiry date	Oct 17, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N9/0051
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD). In particular the present invention relates to RdCVFL polypeptide or polynucleotide for use in the treatment of AMD.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.